Here is how Adicet Bio, Inc. (ACET) and Agilent Technologies (A) have performed compared to their sector so far this year.

Swiss firms are adopting Microsoft AI and cloud technologies to connect data, AI and business processes while maintaining ...

OpenAI says ChatGPT for Teens also uses safeguards that help reduce exposure to potentially inappropriate content, such as topics related to eating disorders, as well as graphic and sexual content.

Roughly 71% of fund managers do not expect any of the AI hyperscalers to announce a cut in capital expenditures this year, accor ...

The US and Canada are locked in last-minute talks to prevent a fresh wave of tariffs from striking at 00:01 ET on Wednesday. US President Donald Trump has vowed to slap 50% duties on $20 billion (€17.

Shoe Carnival differentiates from traditional shoe stores thanks to its upbeat music, open-stock layout, spin-to-win discount wheels and in-store announcer who manages time-sensitive flash sales.

OpenAI is launching a version of ChatGPT designed for teenagers — the first generation to grow up with artificial intelligence — who are already using it for schoolwork, questions about daily life and ...

Marvell Technology (NASDAQ:MRVL) is approaching its Aug. 27 quarterly report with UBS pointing to several areas that could support growth as cloud companies increase spending on AI infrastructure. UBS ...

European government bonds came under significant selling pressure on Tuesday, with France’s 10-year bond yield hitting a 17-year high and Germany’s 10-year Bund yield reaching its highest level since ...

BERLIN, Aug 18 () - German investor morale rose more than expected to 34.2 points in August, the ZEW economic research institute ‌said on Tuesday, as positive quarterly results and export orders ...

Baidu posted a fifth straight drop in quarterly revenue on Tuesday as the Chinese tech giant expressed confidence in its transition to artificial intelligence services to drive long-term growth.That ...

Aug 18 () - Amylyx Pharmaceuticals said on Tuesday its experimental drug met its main goal in a late-stage ‌trial for post-bariatric hypoglycemia, a condition marked by dangerously low ‌blood sugar ...